Indicators

Markets:

News

Latest News about BMRN

Recent news which mentions BMRN

< Previous 1 2 3 4 5 6 7 8 Next >

Preview: Biomarin Pharmaceutical's Earnings

February 24, 2023

Analyst Ratings for Biomarin Pharmaceutical

February 22, 2023

Benzinga's Top Ratings Upgrades, Downgrades For February 22, 2023

February 22, 2023

Benzinga's Top Ratings Upgrades, Downgrades For February 21, 2023

February 21, 2023

3 Prime Healthcare Takeover Targets

February 14, 2023

BioRestorative (NASDAQ: BRTX) Ramps Up Production In Anticipation Of Positive Phase 2 Results

February 03, 2023

BioMarin Valuation Fair, But Expectations From Hemophilia Therapy Too High, Says Analyst

January 30, 2023

Benzinga's Top Ratings Upgrades, Downgrades For January 30, 2023

January 30, 2023

What 5 Analyst Ratings Have To Say About Biomarin Pharmaceutical

January 30, 2023

3 Drug Stocks With Promising Pipelines for 2023

January 23, 2023

Cramer Is Holding This Biotech Stock

January 12, 2023

BioMarin's Growth Prospects Soar with Potential Voxzogo and Roctavian Launches, Analyst Raises Price Target

January 11, 2023

6 Analysts Have This to Say About Biomarin Pharmaceutical

January 11, 2023

2 Top Biotech Stocks Defying the Bear Market

January 10, 2023

Netflix, Workday, Costco, Caterpillar and more: These stocks are Cowen’s favorites for 2023

December 10, 2022

12 Health Care Stocks Moving In Thursday's Pre-Market Session

December 01, 2022

12 Health Care Stocks Moving In Thursday's Pre-Market Session

December 01, 2022

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

December 01, 2022

10 Health Care Stocks Whale Activity In Today's Session

November 29, 2022

Expert Ratings for Biomarin Pharmaceutical

November 29, 2022

Canceled AdCom, UniQure's Hemgenix Approval Show Positive Signs For BioMarin's Hemophilia Candidate

November 23, 2022

Why Biomarin Pharmaceutical Stock Hit A New 52-Week High Today

November 23, 2022

$1.4 Million Bet On This Real Estate Stock? 3 Stocks Insiders Are Buying

November 03, 2022

Expert Ratings for Biomarin Pharmaceutical

October 31, 2022

10 Analysts Have This to Say About Biomarin Pharmaceutical

October 31, 2022

Benzinga's Top Ratings Upgrades, Downgrades For October 31, 2022

October 31, 2022

Mastercard To $428? Plus This Analyst Slashes PT On Intel

October 31, 2022

Why BioMarin Pharmaceuticals Fell 6.9% on Thursday

October 27, 2022

Biomarin Pharmaceutical: Q3 Earnings Insights

October 26, 2022

Recap: Biomarin Pharmaceutical Q3 Earnings

October 26, 2022

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.